PPARGC1A and metabolic dysfunction-associated steatotic liver disease: In the early stages of NAFLD/MAFLD the increased intrahepatic influx of circulating FFAs causes early mitochondrial biogenesis mediated by the activation of PGC1-α and increased β-oxidation rates [160,161].